Correction to: Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’ (Drugs, (2023), 10.1007/s40265-023-01869-6)

Chia Siang Kow; Dinesh Sangarran Ramachandram; Syed Shahzad Hasan

doi:10.1007/s40265-023-01890-9

Correction to: Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’ (Drugs, (2023), 10.1007/s40265-023-01869-6)

Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan

Malaysia Sch of Pharmacy

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Abstract

The title that reads Interleukin-6 Receptor Inhibitors and long COVID Should read Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’ The original article has been corrected.

Original language	English
Pages (from-to)	1065
Number of pages	1
Journal	Drugs
Volume	83
Issue number	11
DOIs	https://doi.org/10.1007/s40265-023-01890-9
Publication status	Published - Jul 2023

Access to Document

10.1007/s40265-023-01890-9

Cite this

@article{741b755af8fd462fa6f57dca4c5e7fdd,

title = "Correction to: Comment on: {\textquoteleft}Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?{\textquoteright} (Drugs, (2023), 10.1007/s40265-023-01869-6)",

abstract = "The title that reads Interleukin-6 Receptor Inhibitors and long COVID Should read Comment on: {\textquoteleft}Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?{\textquoteright} The original article has been corrected.",

author = "Kow, {Chia Siang} and Ramachandram, {Dinesh Sangarran} and Hasan, {Syed Shahzad}",

note = "Publisher Copyright: {\textcopyright} 2023 Springer Nature Switzerland AG.",

year = "2023",

month = jul,

doi = "10.1007/s40265-023-01890-9",

language = "English",

volume = "83",

pages = "1065",

journal = "Drugs",

issn = "0012-6667",

publisher = "Springer - Adis",

number = "11",

}

TY - JOUR

T1 - Correction to

T2 - Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’ (Drugs, (2023), 10.1007/s40265-023-01869-6)

AU - Kow, Chia Siang

AU - Ramachandram, Dinesh Sangarran

AU - Hasan, Syed Shahzad

PY - 2023/7

Y1 - 2023/7

N2 - The title that reads Interleukin-6 Receptor Inhibitors and long COVID Should read Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’ The original article has been corrected.

AB - The title that reads Interleukin-6 Receptor Inhibitors and long COVID Should read Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’ The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85159042202&partnerID=8YFLogxK

U2 - 10.1007/s40265-023-01890-9

DO - 10.1007/s40265-023-01890-9

M3 - Comment / Debate

AN - SCOPUS:85159042202

SN - 0012-6667

VL - 83

SP - 1065

JO - Drugs

JF - Drugs

IS - 11

ER -

Correction to: Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’ (Drugs, (2023), 10.1007/s40265-023-01869-6)

Abstract

Access to Document

Other files and links

Research output

Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’

Cite this